These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9460597)

  • 1. [The nature of the interactions of imipramine and serotonin with human lymphocytes].
    Lesnichuk SA; Katukov VIu; Porodenko NV
    Eksp Klin Farmakol; 1997; 60(6):40-3. PubMed ID: 9460597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes.
    Barkan T; Gurwitz D; Levy G; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2004 May; 14(3):237-43. PubMed ID: 15056483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ca(2+)-channel blockers and binding of tricyclic antidepressive agents].
    Krulík R; Bures P; Fisar Z; Fuksová K; Sikora J; Beitlová D
    Cesk Psychiatr; 1995 Jul; 91(3):143-51. PubMed ID: 7553947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Iodoimipramine, a novel ligand for the serotonin transporter.
    Humphreys CJ; Cassel D; Rudnick G
    Mol Pharmacol; 1989 Oct; 36(4):620-6. PubMed ID: 2811859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant binding to the porcine and human platelet serotonin transporters.
    Humphreys CJ; Levin J; Rudnick G
    Mol Pharmacol; 1988 Jun; 33(6):657-63. PubMed ID: 3380080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1.
    Schloss P; Betz H
    Biochemistry; 1995 Oct; 34(39):12590-5. PubMed ID: 7548008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients.
    González A; Fazzino F; Castillo M; Mata S; Lima L
    Neuroimmunomodulation; 2007; 14(1):8-15. PubMed ID: 17700035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-binding sites in brain and platelets.
    Langer SZ; Galzin AM; Lee CR; Schoemaker H
    Ciba Found Symp; 1986; 123():3-29. PubMed ID: 3816412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    Dumbrille-Ross A; Tang SW
    Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of neuronal MAO activity, 5-HT uptake and imipramine binding by endogenous substances in dog cerebrospinal fluid.
    Egashira T; Takano R; Yamanaka Y
    Biochem Pharmacol; 1987 Jun; 36(11):1781-5. PubMed ID: 3034288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation of substances inhibiting the specific binding of imipramine and serotonin uptake from the brain of the bull].
    Mukhin AG; Kladnitskiĭ AV; Kovaleva ES; Kudriakova TB
    Biull Eksp Biol Med; 1985 Aug; 100(8):197-9. PubMed ID: 2992631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
    O'Riordan C; Phillips OM; Williams DC
    J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphocyte serotonin receptors: a radioreceptor study].
    Vetoshkin AV; Fomenko AM; Zozulia AA
    Biull Eksp Biol Med; 1982 Jul; 94(7):52-3. PubMed ID: 7126826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.